Cargando…
Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model
BACKGROUND: Antiangiogenic therapies are considered promising for the treatment of glioblastoma (GB). The non-collagenous C-terminal globular NC1 domain of type VIII collagen a1 chain, Vastatin, is an endogenous antiangiogenic polypeptide. Sustained enhanced expression of Vastatin was shown to inhib...
Autores principales: | Li, Yi, Li, Jun, Woo, Yat Ming, Shen, Zan, Yao, Hong, Cai, Yijun, Lin, Marie Chia-mi, Poon, Wai Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307880/ https://www.ncbi.nlm.nih.gov/pubmed/28193190 http://dx.doi.org/10.1186/s12885-017-3125-8 |
Ejemplares similares
-
Development and optimization of a self-microemulsifying drug delivery system for ator vastatin calcium by using d-optimal mixture design
por: Yeom, Dong Woo, et al.
Publicado: (2015) -
NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
por: Yahyanejad, Sanaz, et al.
Publicado: (2016) -
Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis
por: Hu, Shen, et al.
Publicado: (2019) -
Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model
por: Angst, Eliane, et al.
Publicado: (2010) -
Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2021)